Avidity Partners Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-115,400
Closed -$29.7M 77
2023
Q3
$29.7M Sell
115,400
-58,600
-34% -$15.7M 1.19% 39
2023
Q2
$49.6M Buy
174,000
+45,200
+35% +$13.5M 1.73% 20
2023
Q1
$35.8M Buy
+128,800
New +$35.6M 1.19% 34
2022
Q4
Sell
-600,000
Closed -$160M 90
2022
Q3
$160M Buy
600,000
+159,434
+36% +$33.9M 3.48% 7
2022
Q2
$89.8M Buy
440,566
+75,566
+21% +$15.4M 2.06% 22
2022
Q1
$76.9M Buy
+365,000
New +$79.4M 1.71% 23
2021
Q3
Sell
-183,900
Closed -$63.7M 108
2021
Q2
$63.7M Buy
+183,900
New +$55.7M 1.72% 19
2020
Q4
Sell
-315,100
Closed -$81.3M 103
2020
Q3
$89.4M Buy
+315,100
New +$87.9M 4.81% 6
2020
Q2
Sell
-62,000
Closed -$19.6M 61
2020
Q1
$19.6M Buy
+62,000
New +$18.8M 2.81% 11

Other funds holding BIIB